Molecules of the PYRIN/NBS/LRR protein family and uses thereof

Details Molecules of the PYRIN/NBS/LRR protein family and uses thereof Molecules of the PYRIN/NBS/LRR protein family and uses thereof

2006-05-09

2006-05-09

Siew, Jeffrey (Department: 1642)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S012200, C530S350000

Reexamination Certificate

active

07041643

ABSTRACT:
Novel PYRIN-2, PYRIN-3, PYRIN-5, PYRIN-6, PYRIN-7, PYRIN-8, PYRIN-10, and PYRIN-11 polypeptides, proteins, and nucleic acid molecules are disclosed. In addition to isolated PYRIN-2, PYRIN-3, PYRIN-5, PYRIN-6, PYRIN-7, PYRIN-8, PYRIN-10, and PYRIN-11 proteins, the invention further provides PYRIN-2, PYRIN-3, PYRIN-5, PYRIN-6, PYRIN-7, PYRIN-8, PYRIN-10, and PYRIN-11 fusion proteins, antigenic peptides and anti-PYRIN-2, -PYRIN-3, -PYRIN-5, -PYRIN-6, -PYRIN-7, -PYRIN-8, -PYRIN-10, and -PYRIN-11 antibodies. The invention also provides PYRIN-2, PYRIN-3, PYRIN-5, PYRIN-6, PYRIN-7, PYRIN-8, PYRIN-10, and PYRIN-11 nucleic acid molecules, recombinant expression vectors containing a nucleic acid molecule of the invention, host cells into which the expression vectors have been introduced and non-human transgenic animals in which a PYRIN-2, PYRIN-3, PYRIN-5, PYRIN-6, PYRIN-7, PYRIN-8, PYRIN-10, or PYRIN-11 gene has been introduced or disrupted. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.

REFERENCES:
patent: 2003/0027757 (2003-02-01), Bertin et al.
patent: 1 285 964 (2003-02-01), None
patent: WO 01/61005 (2001-08-01), None
patent: WO 01/75067 (2001-10-01), None
patent: WO 01/92527 (2001-12-01), None
patent: WO 02/14500 (2002-02-01), None
patent: WO 02/32955 (2002-04-01), None
patent: WO 200232955 (2002-04-01), None
patent: WO 02/40668 (2002-05-01), None
patent: WO 02/48362 (2002-06-01), None
patent: WO 200248362 (2002-06-01), None
Kobe et al. (Curr. Opin. Struct. Biol. 2001; 11:725-732).
Bowie et al (Science, 1990, 257:1306-1310).
Burgess et al (J of Cell Bio. 111:2129-2138, 1990).
Scott et al (Nature Genetics, 1999, 21:440-443).
Bertin et al., “The pyrin domain: A novel motif found in apoptosis and inflammation proteins”, Cell Death Differentiation, Edward Arnold, Oxford, Great Britian, 12(7):1273-1274 (2000).
Dias Neta et al., “IL2-UT0074-040900-153-G02 UT0074 homo sapiens cDNA, mRNA sequence”, Database accession No. BF380801.
DOE Joint Genome Institute, GenBank Accession No. AC012310 (2001).
Martinon et al., GenBank Accession No. AF442488 (2001).
Masumoto et al., “Pyrin N-terminal homology domain- and caspase recruitment domain-dependent oligmerization of ASC”, Biochemical and Biophysical Research Communications, Academic Press Inc., Orlando, Fl, USA, 280(3):652-655 (2001).
Strausberg, GenBank Accession No. BE278926 (2000).
Zhao et al., “CITBI-E1-2565K18.TF CITBI-E1 homo sapiens genomic clone 2565K18, genomic survey sequence”, Database Accession No. AQ424752 XP002269231.
Eck et al. (Gene-Based Therpay, In: The Pharmacological Basis of Therapeutics, Goodman and Gillman, Eds, 1996, pp. 77-101.
Houdebine, Journal of Biotechnology, 1994, vol. 34, pp. 269-287.
Orkin, “Report and Recommendation of the Panel to Assess the NIH Investment in Research on Gene Therapy.”
Tong et al., “A Human Homologue of Mouse Mater, A maternal Effect Gene Essential for Early Embryonic Development,” Human Reproduction 17(4):903-911, 2002.
Verma et al., Nature, 1997, vol. 389, pp. 239-242.

Affiliated with

Also associated with

Rating

Molecules of the PYRIN/NBS/LRR protein family and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Molecules of the PYRIN/NBS/LRR protein family and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Molecules of the PYRIN/NBS/LRR protein family and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3614217